ABSTRACT
INTRODUCTION
Oxidative Stress is involved in the process of development of cancer and tumors. ROS formed due to oxidative stress can damage the macro molecules such as lipids, which react with metals (such as free iron and copper) and produce aldehydes such as malondialdehyde. This can induce mutations or cause breaks in the double chain, produce modifications in guanine and thymine bases, and sister chromatid exchanges, which can affect the activities of signal transduction, transcription factors, and gene tumor suppressors such as p53, playing an important role in apoptosis and in cell cycle control. 1 Chemotherapy as well as radiotherapy for cancer treatment is associated with induction of oxidative stress leading to apoptosis which results in severe side effects. This arises a need for utiliz ing antioxidant potential of phytochemicals of plant origin for effective management of cancer. Murraya koenigii Linn (Rutaceae) commonly known as curry leaf, is an aromatic more or less deciduous shrub tree commonly used in Indian diet. 2 Leaves contain alkaloids such as girinimbin, isomahanimbin, koenine, koenigine, koenidine and koenimbine, Mahanimbicine and bicyclomahanimbicine. 3, 4, 5 Leaves are reported to possess antioxidant, antibacterial, antifungal, larvicidal, anticarcinogenic, hypoglycemic, hypolipidemic and antihypertensive activity. 6 The carbazole alkaloids mahanine, pyrafolineD and murrafolineI have reported to possess significant cytotoxicity against HL60 cells and induce the loss of mi tochondrial membrane potential 7 Mahanine, isolated from the leaves of M. koenigii, has found to have a dose and timedependent antip roliferative activity in acute lymphoid (MOLT3) and chronic myeloid (K562) leukemic cell lines and in the primary cells of leukemic and myeloid patients, with minimal effect on normal immune cells. 8 The in-vitro antitumour activity and antioxidant properties of Girinim bine isolated from the stem bark of Murraya koenigii was studied by Yih et al. 9 Glioblastoma multifome is the most common and deadliest of malignant primary brain tumor in adults and is one of a group of tumors referred to as gliomas. The treatment for glioblastoma mainly includes surgery with radiotherapy and chemotherapy options are rarely available. Therefore, in the present study we have analyzed extracts and alkaloid fractions of Murraya koenigii leaves for their in vitro antioxidant and anticancer ac tivity against glioblastoma U373MG cell lines. 
MATERIAL AND METHODS

Plant material
Leaves of Murraya koenigii (MK) were collected from Kurla market, Mumbai. The plant (specimen#: np140104) was authenticated at Guru Nanak Khalsa College, Department of Botany, Mumbai.
Preparation of plant extracts and fractions
Fresh leaves were air dried, powdered mechanically and passed through 40#. Powdered plant material was extracted in a Soxhlet apparatus using 90% (v/v) ethanol and 100% methanol as solvents to obtain ethanolic extract (EEMK) and methanolic extract (MEMK) respectively. Distillate obtained was heated on a water bath to obtain a dry semisolid paste. Alkaloid fractions were separated from extracts. 10 The dry extracts and their fractions were stored in airtight containers at 24 o c for further experimental use.
In vitro antioxidant assay
DPPH assay
The scavenging activity was determined by DPPH assay previously reported by Blois (2009). 7.9 mg of DPPH was accurately weighed and dissolved in 100 ml methanol to obtain 200 µM solution of DPPH. Aliquots of different concentrations of extracts (10 µg/ml, 20 µg/ml, 30 µg/ ml, 40 µg/ml, 50 µg/ml) and fractions (5 µg/ml, 10 µg/ml, 50 µg/ml, 100 µg/ml, 150 µg/ml, 200 µg/ml) were added to 1 ml of DPPH solution. After incubating test tubes for 30 min in dark, absorbance was measured at 517 nm against blank. 11 Extracts and fractions were compared with standard Quercetin. The radical scavenging activity was calculated from the equa tion:
% radical scavenging activity = (Abs control-Abs sample) Abs control × 100
AbsAbsorbance.
Reducing power assay
Reducing power was determined by previously reported method Oyaizu (1986) The different concentrations of extracts(5 µg/ml, 10 µg/ml, 20 µg/ml, 30 µg/ml, 40 µg/ml) and fractions (5 µg/ml, 10 µg/ml, 50 µg/ml, 100 µg/ml, 150 µg/ml, 200 µg/ml) were mixed with 2.5 ml phosphate buffer ( 0.2 M, pH 6.6) and 2.5 ml K 3 [FE(CN) 6 ]( 1%). The reaction mixture was incubated at 50 o C for 20 min. After incubation, 2.5 ml of TCA (10%) was added and centrifuged at 7000 rpm. for 10 min. 2.5 ml solution from the upper layer was mixed with 2.5 ml distilled water and freshly prepared 0.5 ml FeCl 3 (0.1%). 12 Extracts and fractions were compared with standard Quercetin. Higher absorbance of the reaction mixture indicated greater reducing power.
Inhibition of Lipid peroxidation
Freshly excised rat brain was processed to get 10% homogenate in cold phosphate buffer, pH7.4 Degree of lipid peroxidation was assayed by estimating the TBARS formed. The reaction mixture contains 0.1 ml of different concentrations of extracts (10 µg/ml, 20 µg/ml, 30 µg/ml, 40 µg/ml, 50 µg/ml) and fractions (5 µg/ml, 10 µg/ml, 50 µg/ml, 100 µg/ml, 150 µg/ml, 200 µg/ml) were added to the brain homogenate. 0.2 ml SDS (8.1%), 1.5 ml of acetic acid (20%) solution and 1.5 ml of aqueous solution of TBA (0.8%) were added to the homogenate mixture The mixture was finally made up to 4.0 ml with distilled water, and heated at 95°C for 60 min. After cooling with tap water, 1.0 ml of distilled water and 5.0 ml of mixture of nbutanol and pyridine (5:1) were added, and the mixture was shaken vigorously. After centrifugation at 4000 rpm for 10 min, the absorbance of the organic layer (upper layer) was measured at 532 nm. 13 The radical scavenging activity was calculated from the equation:
% radical scavenging activity = (Abs control-Abs sample) Abs control × 100
Superoxide scavenging assay The method described by Liu et al (1997) was used for determination of superoxide anion scavenging activity of extracts and fractions. Superoxide radicals were generated in 3 ml of Tris-HCl buffer (16 mM, pH 8) containing NBT (50 mM) solution and 1 ml of NADH (78 mM) solution and 1 ml of sample solutions of extracts and fractions at different concentrations. Reaction was initiated by adding 1 ml PMS solution (10 μM,) to the mixture. The reaction mixture was incubated at 25℃ for 5 min, and the absorbance was read at 560 nm by UV-visible spectrophotometer. Decreased absorbance of the reaction mixture indicated increased superoxide anion scavenging activity. 14 The percentage inhibition of superoxide anion generation was calculated using the following formula:
Hydroxyl radical scavenging assay Deoxyribose method of Halliwell et al (1987) was used to determine the hydroxyl radical scavenging activity. The reaction mixture, which contained different concentrations of extracts and fractions, deoxyribose (3.75 mM), H 2 O 2 (1 mM), potassium phosphate buffer (20 mM, pH 7.4), FeCl 3 (0.1 mM), EDTA (0.1 mM) and ascorbic acid (0.1 mM), was incubated in a water bath at (37 ± 0.5)℃ for 1 hr. 1 mL of TBA (1% w/ v) and 1 ml of TCA (2.8% w/v) were added to the mixture and heated in a water bath at 100℃ for 20 min The mixture was then incubated at 37°C for 1 h. After incubation, 1 ml of the incubated mixture was mixed with 1 ml of 10% TCA and 1 ml of 0.5% TBA to develop the chromogen, measured at 532 nm. 15 The radical scavenging activity was calculated from the equation:-
In vitro cytotoxicity evaluation
Cell culture and experiment design The cell lines (U373MG) of glioblastoma human tissue origin) were grown in RPMI 1640 medium containing 10% fetal bovine serum and 2 mM Lglutamine. For present screening experiment, cells were inocu lated into 96 well microtiter plates in 100 µl. After cell inoculation, the microtiter plates were incubated at 37°C, 5% CO 2 , 95% air and 100% relative humidity for 24 h prior to addition of experimental drugs. Extracts EEMK, MEMK, alkaloid fractions EFMK, MFMK and stan dard Adriamycin (ADR) were initially solubilized in dimethyl sulfoxide (DMSO) at 100 mg/ml and diluted to 1 mg/ml using water and stored frozen prior to use. At the time of drug addition, an aliquot of frozen concentrate (1 mg/ml) was thawed and diluted to 100 μg/ml, 200 μg/ml, 400 μg/ml and 800 μg/ml with DMSO. Aliquots of 10 µl of these different drug dilutions were added to the appropriate micro titer wells already containing 90 µl of medium, resulting in the required final drug concen trations i.e.10 μg/ml, 20 μg/ml, 40 μg/ml, 80 μg/ml. 16 Sulphorhodamine B assay Sulforhodamine B (SRB) assay was developed by Skehan and colleagues to measure druginduced cytotoxicity and cell proliferation for large scale drugscreening applications. Its principle is based on the ability of the protein dye sulforhodamine B to bind electrostatically and pH dependent on protein basic amino acid residues of trichloroacetic acid fixed cells. Under mild acidic conditions it binds to and under mild basic conditions it can be extracted from cells and solubilized for measure ment. After incubation for 48 h assay was terminated by the addition of cold TCA. Cells were fixed in situ by the gentle addition of 50 µl of cold 30% (w/v) TCA and incubated for 60 min at 4°C. The supernatant was discarded; the plates were washed five times with tap water and air dried. Sulforhodamine B (SRB) solution (50 µl) at 0.4% (w/v) in 1% acetic acid was added to each of the wells, and plates were incubated for 20 min at room temperature. After staining, unbound dye was recovered and the residual dye was removed by washing five times with 1% acetic acid. The plates were air dried. Bound stain was subsequently eluted with 10 m Mtrizma base, and the absorbance was read on a plate reader at a wave length of 540 nm with 690 nm reference wavelength. Cell cycle analysis The cell cycle analysis by Flow cytometry is the primary method of choice, which allows measuring of drug potency, selectivity and mecha nism of action. Fluorescent dye such as Propidium iodide intercalates between the double stranded nucleic acid to produce red fluorescence. It also binds to double stranded RNA so as to be removed by RNAse. It is important that the cells must be fixed or permeabilised to allow access of the dye because it is not able to penetrate an intact membrane. This dye can be used to determine quantity of cellular DNA and also distribution of cell cycle in population of interest. U373MG cells were plated at a density of 1.5×10 6 cells in a 10 cm dish. Next day, cells were treated with different doses of extracts. After 24 h incubation, cells were harvested and suspended in 1XPBS containing 2% FBS. The cells were fixed with 70% ethanol at 4°C for 1 h followed by the addition of propidium iodide (5 μg/μl) and RNase (10 μg/μl) and further incubated for 3 h at 4°C. The DNA content was evaluated in a flow cytometer 17 (BD FACS Calibur, USA). The data was analyzed using Modfit software (BD, Biosciences, USA)
RESULTS
DPPH assay
EEMK, MEMK, EFMK and MFMK showed promising free radical scav enging effect on DPPH radical in a concentration dependent manner. The IC 50 values of EEMK and MEMK were found to be 10.54 µg/ml and 69.89 µg/ml respectively ( Figure 1 ). The IC 50 values of EFMK and MFMK were found to be 65.05 µg/ml and 63.00 µg/ml respectively ( Figure 2) . The extracts were compared with standard Quercetin having IC 50 value of 17.42 μg/ml.
Reducing power assay-
Reducing power of MEMK was found to be higher than EEMK at 10 µg/ml, 20 µg/ml, 30 µg/ml, 40 µg/ml, 50 µg/ml (Figure 3 ) whereas reduc ing power of EFMK was found to be higher than MFMK at, 10 µg/ml, 50 µg/ml, 100 µg/ml, 150 µg/ml,200 µg/ml (Figure 4 ). Both the extracts and fractions were compared with the reducing power of standard Quercetin.
Inhibition of Lipid peroxidation assay
EEMK, MEMK, EFMK and MFMK elicited concentration dependent inhibition of FeSO4 induced lipid peroxidation in rat brain homogenate. The IC 50 values of EEMK and MEMK were found to be 29.8 μg/ml and 33.9 μg/ml respectively ( Figure 5 ). The IC 50 values of EFMK and MFMK were found to be 84.7 μg/ml and 67.4 μg/ml respectively ( Figure 6 ). IC 50 value of Quercetin was found to be 60.07 μg/ml Superoxide scavenging assay EEMK, MEMK, EFMK and MFMK showed free radical scavenging effect on superoxide radical in a concentration dependent manner. The IC 50 values of EEMK and MEMK were found to be 13.5 µg/ml and 9.33 µg/ml respectively ( Figure 7) . The IC 50 values of EFMK and MFMK were found to be 31.91 µg/ml and 22.62 µg/ml respectively (Figure 8) . The extracts and fractions were compared with standard Ascorbic acid having IC 50 value of 4.87 μg/ml.
Hydroxyl scavenging assay
The IC 50 values of EEMK and MEMK were found to be 10.9 µg/ml and 45.2 µg/ml respectively ( Figure 9 ). The IC 50 values of EFMK and MFMK were found to be 96.1 µg/ml and 75.5 µg/ml respectively ( Figure 10 ) The extracts and fractions were compared with standard Ascorbic acid having IC 50 value of 4.7 μg/ml.
Sulphorhodamine B assay
TThe GI 50 value of MEMK and EEMK was found to be 15 μg/ml and 26.7 μg/ml respectively when compared with standard anticancer drug ADR having GI 50 value of less than 10 µg/ml (Figure 11 ). EFMK and MFMK did not show any significant cytotoxic activity (Figure 13b ). These results indicate that MEMK extract was found to be more potent than EEMK showing less GI 50 value ( Figure 12 ). Fractions EFMK and MFMK did not inhibit the cell growth in cytotoxicity assay.
Cell cycle analysis
Analysis of DNA cell cycle before treatment of EEMK and MEMK shows two different types of cell cycles i.e. diploid and aneuploid cells. (Figure 13a ) Diploid cell cycle was found to be 30.47% of total cell population. Large peak corresponds to G0/G1 phase (red color) with 48.42% cells. Small peak corresponds to G2/M phase (red color) with 13.36% cells. Line represents S phase with 38.22% cells Aneuploid cell cycle was found to be 69.53% of total cell population. Largest peak corresponds to G0/G1 phase (yellow color) with 66.67% cells. Small peak corresponds to G2/M phase (yellow color) with 8. 
DISCUSSION
In the present study, the antioxidant potential of EEMK, MEMK, EFMK and MFMK was evaluated with the help of in-vitro antioxidant models like DPPH free radical scavenging activity, Reducing power assay and Lipid peroxidation, Superoxide radical scavenging activity and Hydroxyl radical scavenging activity. Free radical scavenging activity of the extracts and fractions was eval uated based on their ability to scavenge DPPH. Bleaching of DPPH absorption is a representative of the capacity of the test drug to scavenge free radicals independently. Here, EEMK, MEMK, EFMK and MFMK presented good scavenging of DPPH free radical which might be due to their ability to transfer electrons to the DPPH radical thereby showing reduction in absorbance. In reducing power assay, the antioxidants in extracts and fractions brought about reduction of Fe 3+ to Fe
2+
. The amount of Fe 2+ formed was monitored by measuring the formation of Perl's Prussian blue at 700 nm. Increasing absorbance indicated an increase in the reducing power of extracts and fractions. In the current method effectiveness of EEMK, MEMK, EFMK and MFMK is evaluated as inbition of lipid peroxidation. Extracts and fractions reduced the initiating perferryl radical with the formation of ubisemiquinone and H 2 O 2 . Additionally, it is possible that they might have also eliminated lipid peroxyl radicals. Extracts EEMK and MEMK were found to be exerting more potent antioxidant effect in preventing lipid peroxidation than standard Quercetin. Extracts and fractions exhibited a dose dependent increase in super oxide scavenging activity. MEMK showed stronger superoxide radical scavenging activity than EEMK The fractions exhibited poor scavenging activity as compared to extracts EEMK, MEMK and standard Ascorbic acid. In hydroxyl radical scavenging assay extracts were found to be more potent than fractions in scavenging hydroxyl radicals. Thus, all these observations indicate that extracts exhibit more antioxidant potential than fractions. Among all the assays, it was found that extracts showed significant antioxidant activity against lipid peroxides formed in brain tissue. As brain tissue is rich with lipid content, extracts carry a promising potential to prevent oxidative stress induced complications during cancer therapy of glioblastoma. During evaluation of anticancer activity, in SRB assay, more significant increase in the percentage of dead cells in U373MG glioblastoma cell lines were observed after treatment with MEMK as compared to treat ment with EEMK and fractions EFMK and MFMK, suggesting cytotoxic activity of MEMK. In Flow cytometry analysis, apoptotic cells were found to be present after treatment with MEMK which were not observed on treatment with EEMK and fractions EFMK and MFMK. Thus, flow cytometry analysis further confirmed that the observed cytotoxic effect of MEMK was due to apoptotic mode of action. We found that the methanolic extract of curry leaves significantly decreased cell growth in human glioblastoma cell lines in a dosedepen dent manner whereas alkaloid fractions of the ethanolic and methanolic extract of Murraya koenigii were not found to exhibit significant anticancer effect on glioblastoma cell lines. In conclusion, Murraya koenigii plant extracts and fractions have potent antioxidant activity which might be useful in preventing oxidative stress during cancer treatment. Among both the extracts and fractions, MEMK has ability to produce significant death of U373MG cells whereas its alkaloid fraction has failed to show cytotoxic effect. Hence active component(s) other than alkaloids from methanolic extracts of curry leaves could be responsible for the observed anticancer effect against glioblastoma. In future, if phytoconstituents responsible for anticancer effect on glioblastoma cell line are identified and isolated it could lead to development of novel natural remedy against glioblastoma. Therefore, curry leaves appear to be a promising source of drug candidate for restricting the growth of glioblastoma cancer cells.
